StartPRGO • NYSE
add
Perrigo Company PLC
24,34 $
Efter lukketid:(0,00 %)0,00
24,34 $
Lukket: 13. jan., 17.40.51 GMT-5 · USD · NYSE · Ansvarsfraskrivelse
Seneste lukkekurs
24,38 $
Dagsinterval
24,08 $ - 24,49 $
Årsinterval
23,89 $ - 33,96 $
Markedsværdi
3,32 mia. USD
Gns. volumen
1,30 mio.
P/E-værdi
-
Udbytteprocent
4,54 %
Primær børs
NYSE
I nyhederne
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
(USD) | sep. 2024info | År til år-ændring |
---|---|---|
Indtægt | 1,09 mia. | -3,23 % |
Driftsudgifter | 290,90 mio. | -12,72 % |
Nettoindtægt | -21,00 mio. | -247,89 % |
Overskudsgrad | -1,93 | -253,17 % |
Earnings per share | 0,81 | 26,56 % |
EBITDA | 195,80 mio. | 15,93 % |
Effektiv afgiftssats | 180,73 % | — |
Årsbalance
Samlede aktiver
Samlede passiver
(USD) | sep. 2024info | År til år-ændring |
---|---|---|
Kontanter og korttidsinvesteringer | 1,46 mia. | 144,39 % |
Samlede aktiver | 11,20 mia. | 4,14 % |
Samlede passiver | 6,64 mia. | 10,25 % |
Samlet egenkapital | 4,57 mia. | — |
Shares outstanding | 136,43 mio. | — |
Kurs/indre værdi | 0,73 | — |
Afkast af aktiver | 2,63 % | — |
Afkast af kapital | 3,09 % | — |
Pengestrøm
Nettoændring i likviditet
(USD) | sep. 2024info | År til år-ændring |
---|---|---|
Nettoindtægt | -21,00 mio. | -247,89 % |
Pengestrøm fra drift | 42,20 mio. | -66,10 % |
Pengestrøm fra investering | 212,70 mio. | 792,83 % |
Pengestrøm fra finansiering | 653,30 mio. | 1.608,78 % |
Nettoændring i likviditet | 920,70 mio. | 2.036,19 % |
Fri pengestrøm | 219,62 mio. | 174,19 % |
Om
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Administrerende direktør
Grundlagt
1887
Website
Ansatte
9.140